Journal profile · Clinical Neurology
Neuro-Oncology
ISSN 1522-8517 · eISSN 1523-5866 · Oxford University Press · UNITED STATES · Quarterly · Founded 1999
Neuro-Oncology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 11.75; hybrid open access; APC about USD 5,132; median 137 days to acceptance (98 articles, last 24 months); community-reported acceptance: fairly hard; 2,986 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Neuro-Oncology is published by Oxford University Press and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Glioma Diagnosis and Treatment, Brain Metastases and Treatment and Radiomics and Machine Learning in Medical Imaging, together about 53.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Published monthly from January 2010, Neuro-Oncology is the official journal of the Society for Neuro-Oncology. Also affiliated with the Japan Society for Neuro-Oncology and the European Association of Neuro-Oncology it is a truly global journal in the field. Dedicated to providing superior and rapid publication of information in all areas of neuro-oncology, the journal contains peer-reviewed articles and reviews, symposia on selected topics, published abstracts of annual meetings, and society news and announcements from around the world.
Source: LetPub
Research area (LetPub): Clinical Neurology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glioma Diagnosis and TreatmentMedicine37.9%
- Brain Metastases and TreatmentMedicine9.6%
- Radiomics and Machine Learning in Medical ImagingMedicine6%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.4%
- Meningioma and schwannoma managementMedicine4.2%
- Neuroblastoma Research and TreatmentsMedicine3.8%
- Cancer Research and TreatmentsBiochemistry, Genetics and Molecular Biology3.4%
- CAR-T cell therapy researchMedicine2.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 11.75LetPub ·
- CiteScore 2026-06
- 21.1LetPub ·
- SJR 2026-06
- 5.25LetPub ·
- SNIP 2026-06
- 3.33LetPub ·
- h-index
- 105LetPub ·
- h-index
- 218OpenAlex ·
- i10-index
- 3,144OpenAlex ·
- 2-year mean citedness
- 1.18OpenAlex ·
- Self-citation rate
- 5.3%LetPub ·
- Share of gold OA articles
- 39.62%LetPub ·
Volume
- Articles per year
- 184LetPub ·
Articles by year OpenAlex count · 30,100 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 312 | 257 | 148 |
| 2025 | 2,986 | 2,754 | 1,768 |
| 2024 | 2,962 | 2,961 | 5,483 |
| 2023 | 2,330 | 2,330 | 6,860 |
| 2022 | 2,626 | 2,605 | 12,990 |
| 2021 | 1,712 | 1,577 | 26,950 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
137 daysMedian, submission to acceptance · P25–P75 88 days – 183 days
- Acceptance to online
- median 4 days (64 articles)
- Submission to online
- median 160 days
- Sample
- 98 articles with submission and acceptance dates (650 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,132 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1999
- ISSN
- 1522-8517
- Electronic ISSN
- 1523-5866
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Neuro-Oncology
What CAS zone is Neuro-Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Neuro-Oncology is in Zone 1 of Medicine, and in Zone 1 of the minor category Clinical Neurology / Oncology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Neuro-Oncology?
The latest impact factor listed by LetPub is 11.75; CiteScore 21.1, h-index 218.
How long does peer review take at Neuro-Oncology?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 137 days (interquartile range 88–183 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Neuro-Oncology?
According to LetPub and DOAJ records, Neuro-Oncology is indexed in SCIE and Scopus.
Is Neuro-Oncology open access, and what is the APC?
Neuro-Oncology is a hybrid journal. For open-access publication: APC about USD 5,132.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .